3 European Projects Found
Searched on 125080 European Projects
FINISHED
Antiviral Defense in the Vector Mosquito Aedes aegypti: induction and suppression of RNA silencing pathways (ViVARNAsilencing)
Start date: Aug 1, 2014, End date: Jul 31, 2019,
BACKGROUND: Mosquitoes and other blood-feeding arthropods transmit important human and animal viruses (arthropod-borne viruses, arboviruses). With the increasing global threat of arboviruses, it is essential to understand the virus-vector interactions that determine virus transmission. The mosquito antiviral immune response is a key determinant of virus replication and transmission. We recently sh ...
Read Project
1
Partner Participant
FINISHED
QUantitative Imaging in Cancer: CONnecting CEllular Processes with Therapy (QUIC-CONCEPT)
Start date: Sep 1, 2011, End date: Dec 31, 2017,
The QuIC-ConCePT consortium has 2 objectives: 1.(90% of resource, WP2-5) to qualify 3 specific imaging biomarkers (IBs) of tumour cell proliferation, apoptosis, and necrosis, to allow drug developers to demonstrate reliably modulation of these pathologic processes in tumours in patients in realistic trials. Our vision for January 2016 is that drug developers can incorporate these IBs for decision- ...
Read Project
26
Partners Participants
FINISHED
DRIVING RE-INVESTMENT IN R&D AND RESPONSIBLE ANTIBIOTIC USE (DRIVE-AB)
Start date: Oct 1, 2014, End date: Sep 30, 2017,
Antimicrobial resistance (AMR) is widespread. Its global human and economic burden is tremendous and increasing annually. Yet today only a few pharmaceutical companies retain active antibacterial drug discovery programmes. While the elaboration of antibiotics with novel mechanisms of action is scientifically complex, the chief challenge is diminishing incentives. Pre-market regulatory requirements ...
Read Project
